Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ellana K. Haakenstad"'
Autor:
Elena Garcia Farina, Jessi Rowell, Anna Revette, Ellana K. Haakenstad, Jessica L. F. Cleveland, Rachel Allende, Michael Hassett, Deborah Schrag, Nadine J. McCleary
Publikováno v:
JAMA network open. 5(7)
Often electronic tools are built with English proficient (EP) patients in mind. Cancer patients with limited English proficiency (LEP) experience gaps in care and are at risk for excess toxic effects if they are unable to effectively communicate with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6739628abbc8cd566c63668c178a767
https://pubmed.ncbi.nlm.nih.gov/35867056
https://pubmed.ncbi.nlm.nih.gov/35867056
Publikováno v:
International Journal of Cancer Care and Delivery. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adffb53adefac619944b6464703fa4a8
https://doi.org/10.53876/001c.36116
https://doi.org/10.53876/001c.36116
Autor:
Nadine J McCleary, Ellana K Haakenstad, Jessica L F Cleveland, Michael Manni, Michael J Hassett, Deb Schrag
Publikováno v:
JAMIA open. 5(3)
Objective As part of ongoing implementation of electronic patient-reported outcome tools at the Dana-Farber Cancer Institute, here we describe the development of the electronic New Patient Intake Questionnaire. Materials and Methods The original New
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cab5798960714d1c74bf701bf24e292
https://pubmed.ncbi.nlm.nih.gov/35898610
https://pubmed.ncbi.nlm.nih.gov/35898610
Autor:
Ellana K Haakenstad, Lauren K. Brais, Arrien Bertram, Andrea Kruse, Alissa Gentile, Rachel A. Freedman, Neal Ian Lindeman, Olga N. Kozyreva, Pedro Sanz-Altamira, Christopher S. Lathan, Michael J. Hassett, Ethan Cerami, Annette S. Kim, Danielle Manning, Jonathan Nowak, Marios Giannakis, Robert Coleman Lindsley, William C. Hahn, Bruce E. Johnson, Nadine Jackson McCleary
Publikováno v:
Journal of Clinical Oncology. 41:794-794
794 Background: Tumor genomic testing (GT) has increased diagnostic accuracy and treatment options for patients (pts) with cancer. Dana-Farber Cancer Institute (DFCI) has made GT accessible as an institute-supported research effort for >10 yrs. We es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6392a580d9b51f198473a0c05d770bd5
https://doi.org/10.1200/jco.2023.41.4_suppl.794
https://doi.org/10.1200/jco.2023.41.4_suppl.794
Autor:
Nadine Jackson McCleary, Ellana K. Haakenstad, Bridget Neville, Arrien A. Bertram, Wendy Loeser, Joseph Grider, Andea Kruse, Alissa Gentile, Olga Kozyreva, Pedro Sanz-Altamira, Christopher Lathan, Michael J. Hassett, Ethan Cerami, Annette S. Kim, Marios Giannakis, R. Coleman Lindsley, Neal I. Lindeman, William C. Hahn, Janina Longtine, Barrett Rollins, Levi Garraway, Bruce E. Johnson
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:C070-C070
Background: Lack of representation in genomic databases limits the generalizability of study findings, predictive models, and therapeutics. In cancer, the development of nearly 75% of cancer drugs have been informed by genomic data,1 yet there is per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd7180dbdce11459aa7ac8e025cb3c25
https://doi.org/10.1158/1538-7755.disp22-c070
https://doi.org/10.1158/1538-7755.disp22-c070
Autor:
Nadine Jackson McCleary, Ellana K Haakenstad, Bridget A. Neville, Rachel Weitzner, Sunyi Zhang, Michael Manni, Jessica Cleveland, Deborah H Toffler, Julie P Wallace, Michael J. Hassett
Publikováno v:
Journal of Clinical Oncology. 40:178-178
178 Background: The social determinants of health contribute to patient (pt) health status throughout the cancer care continuum. Here we describe preliminary results of RESOURCE, a pragmatic intervention to ID and intervene on pt resource needs at an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acab8a27a317318cb170debb77b953fe
https://doi.org/10.1200/jco.2022.40.28_suppl.178
https://doi.org/10.1200/jco.2022.40.28_suppl.178